A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Infectious Diseases

• Publication date

  2013-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/infdis/jit104PMID 23493729PMCID PMC3654752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New understandings in Streptococcus pyogenes

  2011cited by this paper
• A Small Molecule That Mimics the BB-loop in the Toll Interleukin-1 (IL-1) Receptor Domain of MyD88 Attenuates Staphylococcal Enterotoxin B-induced Pro-inflammatory Cytokine Production and Toxicity in Mice*

  2011cited by this paper
• Gram‐positive bacterial superantigen outside‐in signaling causes toxic shock syndrome

  2011cited by this paper
• Binding of Superantigen Toxins into the CD28 Homodimer Interface Is Essential for Induction of Cytokine Genes That Mediate Lethal Shock

  2011cited by this paper
• Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections.

  2010cited by this paper
• Molecular pathogenesis of necrotizing fasciitis.

  2010cited by this paper
• A Single, Engineered Protein Therapeutic Agent Neutralizes Exotoxins from Both Staphylococcus aureus and Streptococcus pyogenes

  2010cited by this paper
• Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists

  2007cited by this paper
• Practice guidelines for the diagnosis and management of skin and soft-tissue infections.

  2005cited by this paper
• Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach

  2005cited by this paper
• Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide.

  2004cited by this paper
• Superantigens: microbial agents that corrupt immunity.

  2002cited by this paper
• The Bacterial Superantigen Streptococcal Mitogenic Exotoxin Z Is the Major Immunoactive Agent of Streptococcus pyogenes1

  2002cited by this paper
• Complementation of a speA negative Streptococcus pyogenes with speA: effects on virulence and production of streptococcal pyrogenic exotoxin A.

  2001cited by this paper
• Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation

  2000cited by this paper
• Therapeutic approaches to streptococcal toxic shock syndrome

  1999cited by this paper
• A Mutational Analysis of the Binding of Staphylococcal Enterotoxins B and C3 to the T Cell Receptor β Chain and Major Histocompatibility Complex Class II

  1998cited by this paper
• Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.

  1997cited by this paper
• Detection of circulating bacterial superantigen and lymphotoxin-alpha in patients with streptococcal toxic-shock syndrome.

  1996cited by this paper
• Streptococcal pyrogenic exotoxin A release, distribution, and role in a murine model of fasciitis and multiorgan failure due to Streptococcus pyogenes.

  1996cited by this paper
• Detection of circulating bacterial superantigen and lymphotoxin-a in patients with streptococcal toxic-shock syndrome

  1996cited by this paper
• Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis.

  1993cited by this paper
• T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor

  1992cited by this paper
• The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells

  1990cited by this paper
• Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection

  1989cited by this paper
• The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.

  1988influential reference

• Antibacterials with Novel Chemical Scaffolds in Clinical Development

  2025cites this paper
• CD28 and ICOS in immune regulation: Structural insights and therapeutic targeting.

  2025cites this paper
• Antimicrobial resistance crisis: could artificial intelligence be the solution?

  2024cites this paper
• Subduing the Inflammatory Cytokine Storm

  2024cites this paper
• CD8+ T cells are necessary for improved sepsis survival induced by CD28 agonism in immunologically experienced mice

  2024cites this paper
• Targeting staphylococcal enterotoxin B binding to CD28 as a new strategy for dampening superantigen-mediated intestinal epithelial barrier dysfunctions

  2024cites this paper
• Antistaphylococcal discovery pipeline; where are we now?

  2023cites this paper
• The homodimer interfaces of costimulatory receptors B7 and CD28 control their engagement and pro-inflammatory signaling

  2023cites this paper
• ICU Management of Invasive β-Hemolytic Streptococcal Infections.

  2022cites this paper
• Fighting antibiotic resistance—strategies and (pre)clinical developments to find new antibacterials

  2022cites this paper
• Superantigens, a Paradox of the Immune Response

  2022cites this paper
• A host-directed macrocyclic peptide therapeutic for MDR gram negative bacterial infections

  2021cites this paper
• Binding of Staphylococcal Enterotoxin B (SEB) to B7 Receptors Triggers TCR- and CD28-Mediated Inflammatory Signals in the Absence of MHC Class II Molecules

  2021cites this paper
• Resolution of organ dysfunction as a predictor of long-term survival in necrotizing soft tissue infections: Analysis of the AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections trial and a retrospective claims database-linked chart study

  2021cites this paper
• CD28 Agonism Improves Survival in Immunologically Experienced Septic Mice via IL-10 Released by Foxp3+ Regulatory T Cells

  2020cites this paper
• Host Defense Peptides as Templates for Antifungal Drug Development

  2020influential citation
• A Novel Immune Modulator for Patients With Necrotizing Soft Tissue Infections (NSTI)

  2020cites this paper
• Lung Infections

  2020cites this paper
• Acute Kidney Injury: From Diagnosis to Prevention and Treatment Strategies

  2020cites this paper
• Refinement of LPS induced Sepsis in SD Rats to Mimic Human Sepsis

  2020cites this paper
• egc Superantigens Impair Monocytes/Macrophages Inducing Cell Death and Inefficient Activation

  2020cites this paper
• Prolonged Benefit of Reltecimod Despite Short Plasma Half-Life

  2020cites this paper
• Prolonged Benefit of Reltecimod Despite Short Plasma Half-Life

  2020cites this paper
• Staging and Personalized Intervention for Infection and Sepsis

  2020cites this paper
• Skin and Soft Tissue Infections in ICU

  2020cites this paper
• Treatment with One Dose of Reltecimod is Superior to Two Doses in Mouse Models of Lethal Infection

  2019cites this paper
• Staphylococcal and Streptococcal Superantigens Trigger B7/CD28 Costimulatory Receptor Engagement to Hyperinduce Inflammatory Cytokines

  2019cites this paper
• The Group A Streptococci Bacteriocins Facilitate a Competitive Advantage During Nasopharyngeal Infection

  2019cites this paper
• Bacterial Superantigen Toxins, CD28, and Drug Development

  2018cites this paper
• Novel Immune Therapies in the Management of Streptococcal Sepsis and Necrotizing Soft Tissue Infections

  2018cites this paper
• Über bisherige Denkweisen hinaus - neue Wirkstoffe zur Überwindung der Antibiotika-Krise

  2018cites this paper
• Thinking Outside the Box-Novel Antibacterials To Tackle the Resistance Crisis.

  2018cites this paper
• Fulminating Soft-Tissue Infections

  2017cites this paper
• Bacterial superantigen toxins induce a lethal cytokine storm by enhancing B7-2/CD28 costimulatory receptor engagement, a critical immune checkpoint.

  2017cites this paper
• Superantigen responsive T cells are required for nasopharyngeal infection by Streptococcus pyogenes

  2017cites this paper
• Novel Targets for Drug Development

  2017cites this paper
• Molecular Targets for Therapy

  2017cites this paper
• CD28 Costimulation: From Mechanism to Therapy.

  2016cites this paper
• Superantigens hyperinduce inflammatory cytokines by enhancing the B7-2/CD28 costimulatory receptor interaction

  2016cites this paper
• Innate Immune Signaling Activated by MDR Bacteria in the Airway.

  2016cites this paper
• CD 4 + T Cells Promote the Pathogenesis of Staphylococcus aureus Pneumonia

  2015cites this paper
• Bacterial superantigens and superantigen-like toxins

  2015cites this paper
• CD4+ T cells promote the pathogenesis of Staphylococcus aureus pneumonia.

  2015cites this paper
• CD28 homodimer interface mimetic peptide acts as a preventive and therapeutic agent in models of severe bacterial sepsis and gram-negative bacterial peritonitis.

  2015influential citation
• Strategies to improve drug development for sepsis

  2014cites this paper
• A Novel Drug for Treatment of Necrotizing Soft-Tissue Infections: A Randomized Clinical Trial.

  2014cites this paper
• Functional Genomic Characterization of Virulence Factors from Necrotizing Fasciitis-Causing Strains of Aeromonas hydrophila

  2014cites this paper
• Single Administration of p2TA (AB103), a CD28 Antagonist Peptide, Prevents Inflammatory and Thrombotic Reactions and Protects against Gastrointestinal Injury in Total-Body Irradiated Mice

  2014influential citation
• Treatment for Necrotizing Soft-Tissue Infections: More Skin in the Game.

  2014cites this paper
• Update on Staphylococcal Superantigen-Induced Signaling Pathways and Therapeutic Interventions

  2013cites this paper
• Necrotizing Soft Tissue Infections

  2013cites this paper
• CD28: Direct and Critical Receptor for Superantigen Toxins

  2013cites this paper